| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 08/16/2001 | WO2001059462A1 Method of measuring lipid components and method of examining renal failure |
| 08/16/2001 | WO2001059459A2 Compositions and methods for screening therapeutic agents |
| 08/16/2001 | WO2001059457A2 Assay for detection of viral fusion inhibitors |
| 08/16/2001 | WO2001059453A2 Biosensor compositions and methods of use |
| 08/16/2001 | WO2001059451A1 Enzyme-based gprotein-coupled receptor assay |
| 08/16/2001 | WO2001059450A2 Cells expressing zinc finger protein for drug discovery |
| 08/16/2001 | WO2001059163A2 Method for detecting and quantifying adenovirus |
| 08/16/2001 | WO2001059162A2 METHOD FOR NUCLEIC ACID DETECTION VIA Qβ REPLICASE |
| 08/16/2001 | WO2001059161A2 Analyte assays employing universal arrays |
| 08/16/2001 | WO2001059160A1 Detection of polymorphisms by denaturing high-performance liquid chromatography |
| 08/16/2001 | WO2001059159A2 Molecular biological kit apparatus and method |
| 08/16/2001 | WO2001059158A1 Compositions and methods for the early diagnosis of ovarian cancer |
| 08/16/2001 | WO2001059157A2 Process for the enumeration and identification of microorganisms |
| 08/16/2001 | WO2001059156A2 DETECTION OF BINDING OF CHARGED SPECIES USING pH- OR POTENTIAL-SENSITIVE PROBES |
| 08/16/2001 | WO2001059155A2 Interferon-alpha induced genes |
| 08/16/2001 | WO2001059154A2 Process for characterising nucleic acids in solution |
| 08/16/2001 | WO2001059153A2 Method for identifying substances which modulate the activity of hyperpolarisation-activated cation channels |
| 08/16/2001 | WO2001059152A2 Polymorphisms in the human cyp2b6 gene and their use in diagnostic and therapeutic applications |
| 08/16/2001 | WO2001059151A2 Method of designing and selecting polynucleotide sequences |
| 08/16/2001 | WO2001059150A1 Biomolecular toxicity assay |
| 08/16/2001 | WO2001059149A2 Peptide biosensors for anthrax protease |
| 08/16/2001 | WO2001059148A1 A bacterial vaginosis screening technique and a diagnostic kit for use therein |
| 08/16/2001 | WO2001059145A1 Regulated expression of plac in staphylococcus aureus |
| 08/16/2001 | WO2001059144A1 Method of analyzing single nucleotide polymorphisms using melting curve and restriction endonuclease digestion |
| 08/16/2001 | WO2001059133A1 Larynx carcinoma-associated protein larcap-1 |
| 08/16/2001 | WO2001059129A2 Mammalian secreted group iii phospholipase a2 |
| 08/16/2001 | WO2001059128A2 Novel elongase gene and method for producing multiple-unsaturated fatty acids |
| 08/16/2001 | WO2001059127A2 Drug metabolizing enzymes |
| 08/16/2001 | WO2001059124A1 Microplate fluorescent screening method for detecting gene anomaly allowing convenient and less expensive treatment of specimens on mass scale |
| 08/16/2001 | WO2001059120A2 Il-17 like molecules and uses thereof |
| 08/16/2001 | WO2001059110A2 34p3d7: a tissue specific protein highly expressed in prostate cancer |
| 08/16/2001 | WO2001059103A2 Method and reagent for the modulation and diagnosis of cd20 and nogo gene expression |
| 08/16/2001 | WO2001059101A1 Method for amplifying full length single strand polynucleotide sequences |
| 08/16/2001 | WO2001059100A2 Inhibitor of hepatocyte growth factor activator for use in modulation of angiogenesis and cardiovascularization |
| 08/16/2001 | WO2001059096A1 Method of detecting ligand or ligand-like low-molecular weight compound |
| 08/16/2001 | WO2001059079A1 UDP-GALACTOSE: β-D-GALACTOSE-R 4-α-D-GALACTOSYLTRANSFERASE, α4GAL-T1 |
| 08/16/2001 | WO2001059077A1 Porcine reproductive and respiratory syndrome virus and methods of use |
| 08/16/2001 | WO2001059073A2 Cytotoxic t lymphocytes activated by dendritic cell hybrids |
| 08/16/2001 | WO2001059071A2 Methods of preparing and using a viral vector library |
| 08/16/2001 | WO2001059064A2 Nucleic acids, proteins, and antibodies |
| 08/16/2001 | WO2001059063A2 Nucleic acids, proteins, and antibodies |
| 08/16/2001 | WO2001059060A2 Apparatus and method for surface culture of microorganisms from bulk fluids |
| 08/16/2001 | WO2001058954A2 Trade molecules and uses related thereto |
| 08/16/2001 | WO2001058951A2 Water-soluble ligand-binding proteins of ligand-gated ion channels, crystals thereof and their use for screening ligands of ligand-gated ion channels |
| 08/16/2001 | WO2001058945A1 Dna encoding human vanilloid receptor vr3 |
| 08/16/2001 | WO2001058944A1 Sodium-independent small neutral amino acid transporters transporting l- and d-amino acids and genes thereof |
| 08/16/2001 | WO2001058937A2 Interferon-alpha induced genes |
| 08/16/2001 | WO2001058923A2 Improved systems for sensitive detection of g-protein coupled receptor and orphan receptor function using reporter enzyme mutant complementation |
| 08/16/2001 | WO2001058914A2 Haplotypes of the interleukin 15 gene |
| 08/16/2001 | WO2001058592A1 Method and device for withdrawing suspended microparticles from a fluidic microsystem |
| 08/16/2001 | WO2001058573A1 Optimization of ligand affinity for rna targets using mass spectrometry |
| 08/16/2001 | WO2001058482A1 Anti-human mitochondrial adenylate kinase isozyme antibody, diagnostic formulation and diagnostic kit for cardiac disease |
| 08/16/2001 | WO2001058461A1 Mycobacterium ag85 complex-specific t cell peptides and use in diagnostic and therapeutic applications thereof |
| 08/16/2001 | WO2001058338A2 A method for detecting bacterial exacerbations of chronic lung disease |
| 08/16/2001 | WO2001023601A3 Novel enzymes and metabolites involved in skatole metabolism |
| 08/16/2001 | WO2001023550A3 Pca3 messenger rna species in benign and malignant prostate tissues |
| 08/16/2001 | WO2001012853A8 Method for identification of the indicators of contamination in samples |
| 08/16/2001 | WO2001011024A3 Bryostatins, bryopyrans and polyketides: compositions and methods |
| 08/16/2001 | WO2001009389A3 Methods and apparatus for template capture and normalization for submicroliter reaction |
| 08/16/2001 | WO2001009347A3 Archaeal replication accessory factors and methods of use |
| 08/16/2001 | WO2001009311A9 Methods of inhibiting cancer cells with adnf iii antisense oligonucleotides |
| 08/16/2001 | WO2001009292A3 Sentrin-specific human proteases senp1-3 |
| 08/16/2001 | WO2001007638A3 Homogeneous fluorescence method for assaying structural modifications of biomolecules |
| 08/16/2001 | WO2001007628A3 Human synthetases |
| 08/16/2001 | WO2001007595A3 Novel fibroblast growth factor and nucleic acids encoding same |
| 08/16/2001 | WO2001007583A8 Cell/tissue analysis via controlled electroporation |
| 08/16/2001 | WO2001006019A3 Nucleic acids for detecting parvovirus and methods of using same |
| 08/16/2001 | WO2001004354A3 Use of ras inhibitors of inhibiting muscle atrophy |
| 08/16/2001 | WO2001004343A3 A method for determining the prognosis of cancer patients by measuring levels of bag expression |
| 08/16/2001 | WO2001002599A3 Assay method to identify s-phase cells on cell sections or permeabilised cells and uses thereof |
| 08/16/2001 | WO2001002569A3 Human immune response molecules |
| 08/16/2001 | WO2000079008A3 High throughput assay system |
| 08/16/2001 | WO2000065094A3 Assay of gene expression patterns by multi-fluor fish |
| 08/16/2001 | WO2000065093A9 In situ hybridization methods for reducing the occurrence of false positives and for targeting multiple microorganisms |
| 08/16/2001 | WO2000063422A3 Detection of biological warfare agents |
| 08/16/2001 | WO2000058506A3 Susceptibility to psoriasis |
| 08/16/2001 | WO2000058352A3 Barley gene for thioredoxin and nadp-thioredoxin reductase |
| 08/16/2001 | WO2000047752A3 Macular degeneration diagnostics and therapeutics |
| 08/16/2001 | WO2000046367A3 Proteins capable of triggering g2/m transition and of interacting with cdc2- and cyclin b |
| 08/16/2001 | WO2000044782B1 Ewing's tumour antigen, nucleic acid and antibodies |
| 08/16/2001 | WO2000037684A9 High throughput assay system using mass spectrometry |
| 08/16/2001 | WO2000036093A9 Intein-mediated cyclization of peptides |
| 08/16/2001 | WO2000023603A9 Methods of treatment of type 2 diabetes |
| 08/16/2001 | WO2000006739A3 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 08/16/2001 | WO2000004156A3 SEROTYPE-SPECIFIC PROBES FOR $i(LISTERIA MONOCYTOGENES) |
| 08/16/2001 | WO2000003025A3 Method of genetic modification of a wild type viral sequence |
| 08/16/2001 | US20010014850 Methods of analyzing polymers using a spatial network of fluorophores and fluorescence resonance energy transfer |
| 08/16/2001 | US20010014673 Genetic engineering |
| 08/16/2001 | US20010014474 Preparing hybridoma cell line which produces antibody which specifically recognizes and binds to cell surface antigen associated with a neoplastic human cell; diagnosis, therapy |
| 08/16/2001 | US20010014468 Magnetic polymer particles on the basis of polyvinyl alcohol, process for the production and use |
| 08/16/2001 | US20010014462 Coupling an enzyme-substrate reaction with a tetrazolium salt and the transfer of free electrons from the reaction to the tetrazolium salt to produce a fluorescent formazan while assaying for enzyme activity; nonradioactive detection |
| 08/16/2001 | US20010014461 For diagnosis, drug discovery; both parallel and muliplex analyte processing capabilities; retentate chromatography is a combinatorial method to provide high information resolution of analytes in complex mixtures |
| 08/16/2001 | US20010014460 Determining whether the Fc-gamma receptor allelic pattern of the patient corresponds most closely to known Fc-gamma allelic patterns of patients having severe, mild, or no autoimmune disease to determine susceptibility |
| 08/16/2001 | US20010014459 By detecting the presence of metaplastic cells expressing spasmolytic peptide which have Brunner's gland morphology in gastric tissues of the patient; kits |
| 08/16/2001 | US20010014458 Human G-protein coupled receptor GPR6sb |
| 08/16/2001 | US20010014456 Binding molecules for human factor VIII and factor VIII-like proteins |
| 08/16/2001 | US20010014455 Assay for disease related conformation of a protein and isolating same |
| 08/16/2001 | US20010014453 Such as N,N-bis(2-trimethoxysilylpropyl)ethanolamine; for silanation of surfaces such as glass and subsequent immobilization of nucleic acids and polypeptides |
| 08/16/2001 | US20010014452 For the fluorometric detection of complementary DNA fragments; water soluble |
| 08/16/2001 | US20010014451 Nucleic acid detection |